Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 21
Filtrar
1.
Sci Total Environ ; 857(Pt 3): 159635, 2023 Jan 20.
Artículo en Inglés | MEDLINE | ID: mdl-36280081

RESUMEN

Climate change is impairing tree physiology and growth, causing an increase in tree dieback in many Mediterranean forests. These desiccation phenomena are leading to changes in land cover and plant community composition. Mediterranean plants are capable to emit large amount of Biogenic Volatile Organic Compounds (BVOCs), whose emission and biosynthesis is strongly affected by environmental conditions. This study evaluates the seasonal changes in understory species composition in two forest stands in Southern Tuscany characterized by different levels of Quercus ilex L. crown defoliation (low and high defoliation, LD and HD) and the relationship with BVOCs emissions over three years. We found significant changes in the understory plant community following Q. ilex crown defoliation and mortality, observing an increment in the number of shrubs both in HD and LD stands. The environmental sampling of BVOCs fully reflected the changes in vegetation cover and composition, with a reduction in the amount of monoterpene emissions due to the increasing rates of defoliation and mortality of Q. ilex trees. Our results suggest that terpene emissions from Mediterranean forests would be modified by an increase of Q. ilex dieback, with important consequences for functioning of this forest ecosystem and its atmospheric chemistry.


Asunto(s)
Quercus , Compuestos Orgánicos Volátiles , Quercus/fisiología , Sequías , Ecosistema , Bosques , Árboles , Plantas
2.
Plant Physiol Biochem ; 183: 151-159, 2022 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-35598532

RESUMEN

Arundo donax L. is an invasive species that has been recently employed for biomass production due to its well-known ability to colonize harsh environment. Based on previous observations, the present study investigated the potential role of phenylpropanoids and class III peroxidases to confer adaptation through biochemical and transcriptomic analysis in A. donax after Na+ and P excess supply, both in single stress and in combination, and after growth at low P level. The levels of hydrogen peroxide, flavonoids (i.e., quercetin, apigenin and kaempferol derivatives) and the activity of class III peroxidases, as well as the expression of several genes encoding for their enzymes involved in their biosynthesis, increased when Na+ was supplied in combination with P. These results suggest that those biomolecules are involved in the response of A. donax, to the presence of +Na and P in the soil. Moreover, even though at the sampling time no significant accumulation of lignin has been determined, the trend of accumulation of such metabolite and most of all the increase of several transcripts involved in its synthesis was found. This work for the first time indicates the need for further investigation devoted to elucidating whether the strengthening of cell walls via lignin synthesis is one of the mechanisms used by A. donax to adapt to harsh environments.


Asunto(s)
Peroxidasa , Fósforo , Lignina/metabolismo , Peroxidasa/metabolismo , Peroxidasas/metabolismo , Fósforo/metabolismo , Poaceae/genética , Cloruro de Sodio/metabolismo
4.
Environ Pollut ; 213: 988-995, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-26809503

RESUMEN

Emission of BVOC (Biogenic Volatile Organic Compounds) from plant leaves in response to ozone exposure (O3) and nitrogen (N) fertilization is poorly understood. For the first time, BVOC emissions were explored in a forest tree species (silver birch, Betula pendula) exposed for two years to realistic levels of O3 (35, 48 and 69 ppb as daylight average) and N (10, 30 and 70 kg ha(-1) yr(-1), applied weekly to the soil as ammonium nitrate). The main BVOCs emitted were: α-pinene, ß-pinene, limonene, ocimene, (E)-4,8-dimethyl-1,3,7-nonatriene (DMNT) and hexanal. Ozone exposure increased BVOC emission and reduced total leaf area. The effect on emission was stronger when a short-term O3 metric (concentrations at the time of sampling) rather than a long-term one (AOT40) was used. The effect of O3 on total leaf area was not able to compensate for the stimulation of emission, so that responses to O3 at leaf and whole-plant level were similar. Nitrogen fertilization increased total leaf area, decreased α-pinene and ß-pinene emission, and increased ocimene, hexanal and DMNT emission. The increase of leaf area changed the significance of the emission response to N fertilization for most compounds. Nitrogen fertilization mitigated the effects of O3 exposure on total leaf area, while the combined effects of O3 exposure and N fertilization on BVOC emission were additive and not synergistic. In conclusion, O3 exposure and N fertilization have the potential to affect global BVOC via direct effects on plant emission rates and changes in leaf area.


Asunto(s)
Atmósfera/química , Betula/efectos de los fármacos , Nitrógeno/metabolismo , Ozono/farmacología , Suelo/química , Terpenos/metabolismo , Compuestos Orgánicos Volátiles/metabolismo , Betula/crecimiento & desarrollo , Betula/metabolismo , Fertilizantes , Aceites Volátiles/metabolismo , Hojas de la Planta/efectos de los fármacos , Hojas de la Planta/crecimiento & desarrollo , Hojas de la Planta/metabolismo , Árboles/efectos de los fármacos , Árboles/crecimiento & desarrollo , Árboles/metabolismo
5.
Eur Rev Med Pharmacol Sci ; 18(20): 3139-43, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25392117

RESUMEN

OBJECTIVE: Paracetamol /codeine has shown a strong analgesic activity in several studies conducted among different kind of subjects, including those with trauma. Nevertheless, its efficacy in patients accessing the Emergency Department (ED) for different kind of pain has never been tested. PATIENTS AND METHODS: This is a cross-sectional, observational, prospective, cohort study. Inclusion criteria were patients > 18 year old presenting to the ED for localized traumatic or inflammatory pain involving only extremities. Numeric scale (NRS) was recorded thirty minutes and two hours after the administration of the analgesic therapy, consisting of 15 mg of ketorolac or 1000 mg/60 mg of paracetamol/ codeine, both orally. RESULTS: Two-hundred patients were consecutively enrolled; 87 were treated with paracetamol/codeine and 113 with ketorolac. The combination paracetamol/codeine resulted to be not inferior to ketorolac in non-traumatic pain group and trauma group (p = 0.635 and p = 0.482, respectively). Compared to ketorolac, the combination paracetamol/codeine exerted a significantly higher analgesic activity in patients with fractures and muscular pain (p = 0.044) and was more effective in acute pain (p = 0.002), with a significant effect two hours after the administration (p = 0.029). CONCLUSIONS: Paracetamol/codeine is equivalent to ketorolac in non-traumatic pain and post-traumatic pain, but is superior in acute pain and in patients with fractures and muscular pain. Those results play in favor of the use of the combination paracetamol/codeine in patients accessing the ED for non-traumatic or traumatic pain of the extremities.


Asunto(s)
Acetaminofén/administración & dosificación , Codeína/administración & dosificación , Servicio de Urgencia en Hospital , Ketorolaco/uso terapéutico , Manejo del Dolor/métodos , Dolor/diagnóstico , Dolor/tratamiento farmacológico , Dolor Agudo/diagnóstico , Dolor Agudo/epidemiología , Adulto , Anciano , Analgésicos no Narcóticos/administración & dosificación , Antiinflamatorios no Esteroideos/administración & dosificación , Estudios de Cohortes , Estudios Transversales , Combinación de Medicamentos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Dolor/epidemiología , Dimensión del Dolor/efectos de los fármacos , Dimensión del Dolor/métodos , Estudios Prospectivos
6.
J Wildl Dis ; 44(1): 109-20, 2008 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-18263826

RESUMEN

Frog virus 3 (FV3) and FV3-like viruses, are members of the genus Ranavirus (family Iridoviridae), and they have been associated with infectious diseases that may be contributing to amphibian population declines. We examined the mode of transmission of an FV3-like virus, and potential hosts and reservoirs of the virus in a local amphibian community. Using the polymerase chain reaction to detect infected animals, we found an FV3-like virus in south-central Ontario, Canada, amphibian communities, where it infects sympatric amphibian species, including ranid and hylid tadpoles (Rana sylvatica, Hyla versicolor, and Pseudacris spp.), larval salamanders (Ambystoma spp.), and adult eastern-spotted newts (Notophthalmus viridescens). The high prevalence of FV3-like infections in caudate larvae suggests that salamanders are likely to be both hosts and reservoirs. In laboratory FV3 challenges of R. sylvatica, the rate of infection was dependent on the amount of virus to which the animals were exposed. In addition, although vertical transmission was suspected, horizontal transmission through exposure to infected pond water is the most likely route of infection in tadpoles. Based on our observations, a simple model of FV3/FV3-like virus transmission postulates that, in aquatic amphibian communities, transmission of the virus occurs between anuran and urodele species, with ambystomatid salamanders the most likely reservoir for the ranavirus in our study.


Asunto(s)
Anfibios/virología , Infecciones por Virus ADN/veterinaria , Ranavirus/patogenicidad , Microbiología del Agua , Animales , Infecciones por Virus ADN/epidemiología , Infecciones por Virus ADN/transmisión , Reservorios de Enfermedades/veterinaria , Transmisión de Enfermedad Infecciosa/veterinaria , Femenino , Interacciones Huésped-Patógeno , Larva , Masculino , Ontario/epidemiología , Prevalencia , Ranavirus/aislamiento & purificación , Salamandridae/virología , Especificidad de la Especie , Urodelos/virología , Carga Viral/veterinaria
7.
Curr Biol ; 11(20): 1578-85, 2001 Oct 16.
Artículo en Inglés | MEDLINE | ID: mdl-11676917

RESUMEN

BACKGROUND: A fundamental challenge of evolutionary and developmental biology is understanding how new characters arise and change. The recently derived eyespots on butterfly wings vary extensively in number and pattern between species and play important roles in predator avoidance. Eyespots form through the activity of inductive organizers (foci) at the center of developing eyespot fields. Foci are the proposed source of a morphogen, the levels of which determine the color of surrounding wing scale cells. However, it is unknown how reception of the focal signal translates into rings of different-colored scales, nor how different color schemes arise in different species. RESULTS: We have identified several transcription factors, including butterfly homologs of the Drosophila Engrailed/Invected and Spalt proteins, that are deployed in concentric territories corresponding to the future rings of pigmented scales that compose the adult eyespot. We have isolated a new Bicyclus anynana wing pattern mutant, Goldeneye, in which the scales of one inner color ring become the color of a different ring. These changes correlate with shifts in transcription factor expression, suggesting that Goldeneye affects an early regulatory step in eyespot color patterning. In different butterfly species, the same transcription factors are expressed in eyespot fields, but in different relative spatial domains that correlate with divergent eyespot color schemes. CONCLUSIONS: Our results suggest that signaling from the focus induces nested rings of regulatory gene expression that subsequently control the final color pattern. Furthermore, the remarkably plastic regulatory interactions downstream of focal signaling have facilitated the evolution of eyespot diversity.


Asunto(s)
Mariposas Diurnas/genética , Proteínas de Homeodominio/genética , Pigmentación/genética , Factores de Transcripción/genética , Alas de Animales/fisiología , Animales , Evolución Biológica , Mariposas Diurnas/crecimiento & desarrollo , Proteínas de Drosophila , Variación Genética/genética , Proteínas de Homeodominio/metabolismo , Mutación/genética , Pupa/crecimiento & desarrollo , Pupa/metabolismo , Homología de Secuencia , Factores de Transcripción/metabolismo , Alas de Animales/crecimiento & desarrollo
8.
Br J Cancer ; 84(9): 1166-71, 2001 May 04.
Artículo en Inglés | MEDLINE | ID: mdl-11336465

RESUMEN

The present study was aimed at defining the antitumour activity of the cisplatin-paclitaxel-topotecan (CPT) weekly administration with G-CSF support in chemo-naive SCLC patients with extensive disease (ED-SCLC). Chemonaive ED-SCLC patients received cisplatin 40 mg/m(2), paclitaxel 85 mg/m(2), and topotecan 2.25 mg/m(2)weekly, with G-CSF (5 microg/kg days 3-5) support, for a maximum of 12 weeks. 37 patients were treated, for a total of 348 cycles delivered. 8 complete responses (22%) and 22 partial responses (59%) were recorded, giving an 81% [95% CI = 65-92%] ORR. At a 13-month (range, 4-26) median follow-up, median progression-free and overall survival were 8 months and 12.5 months, with 1-year and 2-year projected survivals of 55% and 21%, respectively. No toxic deaths occurred. Grade 4 neutropenia and thrombocytopenia occurred in 6 and 3 patients, respectively. Only one case of neutropenic sepsis was recorded, while haemorrhagic thrombocytopenia was never observed. Diarrhoea, paraesthesias and fatigue were the main nonhaematologic toxicities being severe in 6, 2 and 10 patients, respectively. The weekly CPT combination with G-CSF support represents a well tolerated therapeutic approach in chemo-naive ED-SCLC patients. The activity rate seems at least similar to that achievable with the standard front-line approaches.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Carcinoma de Células Pequeñas/tratamiento farmacológico , Neoplasias Pulmonares/tratamiento farmacológico , Adulto , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Carcinoma de Células Pequeñas/patología , Cisplatino/administración & dosificación , Supervivencia sin Enfermedad , Esquema de Medicación , Femenino , Factor Estimulante de Colonias de Granulocitos/administración & dosificación , Humanos , Neoplasias Pulmonares/patología , Masculino , Persona de Mediana Edad , Neutropenia/inducido químicamente , Paclitaxel/administración & dosificación , Taxoides , Trombocitopenia/inducido químicamente , Topotecan/administración & dosificación
9.
J Virol ; 75(2): 821-33, 2001 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11134295

RESUMEN

Alphaherpesviruses spread rapidly through dermal tissues and within synaptically connected neuronal circuitry. Spread of virus particles in epithelial tissues involves movement across cell junctions. Herpes simplex virus (HSV), varicella-zoster virus (VZV), and pseudorabies virus (PRV) all utilize a complex of two glycoproteins, gE and gI, to move from cell to cell. HSV gE/gI appears to function primarily, if not exclusively, in polarized cells such as epithelial cells and neurons and not in nonpolarized cells or cells that form less extensive cell junctions. Here, we show that HSV particles are specifically sorted to cell junctions and few virions reach the apical surfaces of polarized epithelial cells. gE/gI participates in this sorting. Mutant HSV virions lacking gE or just the cytoplasmic domain of gE were rarely found at cell junctions; instead, they were found on apical surfaces and in cell culture fluids and accumulated in the cytoplasm. A component of the AP-1 clathrin adapter complexes, mu1B, that is involved in sorting of proteins to basolateral surfaces was involved in targeting of PRV particles to lateral surfaces. These results are related to recent observations that (i) HSV gE/gI localizes specifically to the trans-Golgi network (TGN) during early phases of infection but moves out to cell junctions at intermediate to late times (T. McMillan and D. C. Johnson, J. Virol., in press) and (ii) PRV gE/gI participates in envelopment of nucleocapsids into cytoplasmic membrane vesicles (A. R. Brack, B. G. Klupp, H. Granzow, R. Tirabassi, L. W. Enquist, and T. C. Mettenleiter, J. Virol. 74:4004-4016, 2000). Therefore, interactions between the cytoplasmic domains of gE/gI and the AP-1 cellular sorting machinery cause glycoprotein accumulation and envelopment into specific TGN compartments that are sorted to lateral cell surfaces. Delivery of virus particles to cell junctions would be expected to enhance virus spread and enable viruses to avoid host immune defenses.


Asunto(s)
Complejo 1 de Proteína Adaptadora , Subunidades mu de Complejo de Proteína Adaptadora , Células Epiteliales/virología , Uniones Intercelulares/virología , Simplexvirus/fisiología , Proteínas del Envoltorio Viral/metabolismo , Virión/fisiología , Subunidades alfa de Complejo de Proteína Adaptadora , Proteínas Adaptadoras del Transporte Vesicular , Animales , Células Cultivadas , Herpesvirus Suido 1/fisiología , Humanos , Proteínas de la Membrana/metabolismo , Microscopía Electrónica , Simplexvirus/genética , Simplexvirus/patogenicidad , Proteínas del Envoltorio Viral/genética , Virión/patogenicidad
10.
J Virol ; 74(5): 2278-87, 2000 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-10666258

RESUMEN

Herpes simplex virus (HSV) expresses a number of membrane glycoproteins, including gB, gD, and gH/gL, that function in both entry of virus particles and movement of virus from an infected cell to an uninfected cell (cell-to-cell spread). However, a complex of HSV glycoproteins gE and gI (gE/gI) is required for efficient cell-to-cell spread, especially between cells that form extensive cell junctions, yet it is not necessary for entry of extracellular virions. We previously showed that gE/gI has the capacity to localize specifically to cell junctions; the glycoprotein complex was found at lateral surfaces of cells in contact with other cells but not at those lateral surfaces not forming junctions or at apical surfaces. By virtue of these properties, gE/gI is an important molecular handle on the poorly understood process of cell-to-cell spread. Here, we show that the cytoplasmic domain of gE is important for the proper delivery of gE/gI to lateral surfaces of cells. Without this domain, gE/gI is found on the apical surface of epithelial cells, and more uniformly in the cytoplasm, although incorporation into the virion envelope is unaffected. However, even without proper trafficking signals, a substantial fraction of gE/gI retained the capacity to accumulate at cell junctions. Therefore, the extracellular domain of gE can mediate accumulation of gE/gI at cell junctions, if the glycoprotein can be delivered there, probably through interactions with ligands on the opposing cell. The role of phosphorylation of the cytoplasmic domain of gE was also studied. A second mutant HSV type 1 was constructed in which three serine residues that form a casein kinase II phosphorylation site were changed to alanine residues, reducing phosphorylation by 70 to 80%. This mutation did not affect accumulation at cell junctions or cell-to-cell spread.


Asunto(s)
Herpesvirus Humano 1/patogenicidad , Uniones Intercelulares/virología , Proteínas del Envoltorio Viral/análisis , Alanina/química , Secuencia de Aminoácidos , Sustitución de Aminoácidos , Animales , Transporte Biológico , Chlorocebus aethiops , Células Epiteliales/virología , Glicoproteínas/análisis , Herpesvirus Humano 1/genética , Herpesvirus Humano 1/metabolismo , Datos de Secuencia Molecular , Fosforilación , Mutación Puntual , Serina/química , Fracciones Subcelulares/virología , Células Vero , Proteínas del Envoltorio Viral/química , Proteínas del Envoltorio Viral/genética , Virión/metabolismo
11.
J Clin Oncol ; 18(2): 405-11, 2000 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-10637256

RESUMEN

PURPOSE: To determine the maximum-tolerated dose of gemcitabine when combined with a fixed dose of vinorelbine in the treatment of non-small-cell lung cancer (NSCLC) and to evaluate in a phase II trial the activity of this combination. PATIENTS AND METHODS: Sixty-eight patients with stage IIIB/IV NSCLC were treated with vinorelbine at fixed dose of 30 mg/m(2) intravenously and gemcitabine at increasing dose levels from 800 to 1,500 mg/m(2) intravenously on days 1 and 8 every 3 weeks. RESULTS: In phase I, dose-limiting toxicity occurred at the dosage of 1,500 mg/m(2) gemcitabine, with three of five patients developing grade 4 thrombocytopenia. In phase II, with gemcitabine at 1,200 mg/m(2), 19 (36%) of 52 assessable patients responded. Objective response was observed in 11 (39%) of 28 patients with stage IIIB disease and in eight (33%) of 24 patients with stage IV. The median time to progression was 29 weeks (range, 2 to 41 weeks; 35 weeks and 16 weeks for stages IIIB and IV, respectively), and median survival was 54 weeks (range, 2 to 84+ weeks; 63 weeks and 42 weeks for stages IIIB and IV, respectively). One-year survival was 64% for patients with stage IIIB disease and 29% for those with stage IV. Clinical benefit response was observed in 29 (59%) of 49 assessable patients. Grade 4 leukopenia and thrombocytopenia were uncommon (6% and 8% of cases, respectively); however, grade 3/4 leukothrombocytopenia occurred more frequently in patients aged more than 70 years (52% and 24%, respectively). CONCLUSION: The combination of vinorelbine and gemcitabine is effective and tolerable in the treatment of NSCLC, thus deserving randomized trials with cisplatin combination regimens.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Carcinoma de Pulmón de Células no Pequeñas/tratamiento farmacológico , Neoplasias Pulmonares/tratamiento farmacológico , Adulto , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Carcinoma de Pulmón de Células no Pequeñas/patología , Desoxicitidina/administración & dosificación , Desoxicitidina/análogos & derivados , Relación Dosis-Respuesta a Droga , Femenino , Humanos , Infusiones Intravenosas , Leucopenia/inducido químicamente , Neoplasias Pulmonares/patología , Masculino , Persona de Mediana Edad , Análisis de Supervivencia , Trombocitopenia/inducido químicamente , Resultado del Tratamiento , Vinblastina/administración & dosificación , Vinblastina/análogos & derivados , Vinorelbina , Gemcitabina
12.
Curr Biol ; 9(22): 1279-87, 1999 Nov 18.
Artículo en Inglés | MEDLINE | ID: mdl-10574759

RESUMEN

BACKGROUND: The morphological diversity of arthropods makes them attractive subjects for studying the evolution of developmental mechanisms. Comparative analyses suggest that arthropod diversity has arisen largely as a result of changes in expression patterns of genes that control development. Direct analysis of how a particular gene functions in a given species during development is hindered by the lack of broadly applicable techniques for manipulating gene expression. RESULTS: We report that the Arbovirus Sindbis can be used to deliver high levels of gene expression in vivo in a number of non-host arthropod species without causing cytopathic effects in infected cells or impairing development. Using recombinant Sindbis virus, we investigated the function of the homeotic gene Ultrabithorax in the development of butterfly wings and beetle embryos. Ectopic Ultrabithorax expression in butterfly forewing imaginal discs was sufficient to cause the transformation of characteristic forewing properties in the adult, including scale morphology and pigmentation, to those of the hindwing. Expression of Ultrabithorax in beetle embryos outside of its endogenous expression domain affected normal development of the body wall cuticle and appendages. CONCLUSIONS: The homeotic genes have long been thought to play an important role in the diversification of arthropod appendages. Using recombinant Sindbis virus, we were able to investigate homeotic gene function in non-model arthropod species. We found that Ultrabithorax is sufficient to confer hindwing identity in butterflies and alter normal development of anterior structures in beetles. Recombinant Sindbis virus has broad potential as a tool for analyzing how the function of developmental genes has changed during the diversification of arthropods.


Asunto(s)
Proteínas de Unión al ADN/biosíntesis , Proteínas de Drosophila , Regulación del Desarrollo de la Expresión Génica , Regulación Viral de la Expresión Génica , Genes Homeobox , Vectores Genéticos/genética , Proteínas de Homeodominio/biosíntesis , Virus Sindbis/genética , Factores de Transcripción , Animales , Artemia/embriología , Artemia/genética , Mariposas Diurnas/crecimiento & desarrollo , Mariposas Diurnas/ultraestructura , Efecto Citopatogénico Viral , Proteínas de Unión al ADN/genética , Drosophila melanogaster/genética , Cabeza/embriología , Hemípteros/embriología , Hemípteros/genética , Proteínas de Homeodominio/genética , Larva , Morfogénesis/genética , Especificidad de Órganos , Pigmentación/genética , Pupa , Proteínas Recombinantes de Fusión/análisis , Recombinación Genética , Especificidad de la Especie , Tórax/embriología , Tribolium/embriología , Tribolium/ultraestructura , Alas de Animales/ultraestructura
13.
Clin Ter ; 150(3): 225-9, 1999.
Artículo en Italiano | MEDLINE | ID: mdl-10528436

RESUMEN

Vinorelbine is effective in the treatment of a number of malignancies. However, beside the haematologic and not haematologic toxicity as thrombocytopenia, granulocytopenia, fatigue, paresthesias, nausea and vomiting, one of the most common side effects is the local irritation with thrombophlebitis. The side effect, reported in about 10-26% of patients receiving vinorelbine infusions, is due to the vescicant and irritant action of the drug. Many studies have been performed in order to reduce the incidence of venous irritation either with concomitant administration of anti-inflammatory drugs as defibrotide or ketorolac, or changing infusion schedule from bolus infusion to a 20-30 minute infusion. Aim of this review is to define peripheral venous system toxicity of vinorelbine and the best way of administration.


Asunto(s)
Antineoplásicos Fitogénicos/efectos adversos , Flebitis/inducido químicamente , Flebitis/prevención & control , Venas/efectos de los fármacos , Vinblastina/análogos & derivados , Antiinflamatorios/administración & dosificación , Antiinflamatorios/uso terapéutico , Antiinflamatorios no Esteroideos/administración & dosificación , Antiinflamatorios no Esteroideos/uso terapéutico , Antineoplásicos Fitogénicos/administración & dosificación , Dexametasona/administración & dosificación , Dexametasona/uso terapéutico , Humanos , Hidrocortisona/administración & dosificación , Hidrocortisona/uso terapéutico , Infusiones Intravenosas , Ketorolaco/administración & dosificación , Ketorolaco/uso terapéutico , Inhibidores de Agregación Plaquetaria/administración & dosificación , Inhibidores de Agregación Plaquetaria/uso terapéutico , Polidesoxirribonucleótidos/administración & dosificación , Polidesoxirribonucleótidos/uso terapéutico , Ensayos Clínicos Controlados Aleatorios como Asunto , Factores de Tiempo , Vinblastina/administración & dosificación , Vinblastina/efectos adversos , Vinorelbina
14.
J Virol ; 72(4): 3330-9, 1998 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-9525660

RESUMEN

Herpes simplex virus (HSV) glycoprotein D (gD) is modified with mannose 6-phosphate (M6P) and binds to M6P receptors (MPRs). MPRs are involved in the well-characterized pathway by which lysosomal enzymes are directed to lysosomes via a network of endosomal membranes. Based on the impaired ability of HSV to form plaques under conditions in which glycoproteins could not interact with MPRs, we proposed that MPRs may function during HSV egress or cell-to-cell spread (C. R. Brunetti, R. L. Burke, B. Hoflack, T. Ludwig, K. S. Dingwell, and D. C. Johnson, J. Virol. 69:3517-3528, 1995). To further analyze M6P modification and intracellular trafficking of gD in the absence of other HSV proteins, adenovirus (Ad) vectors were used to express soluble and membrane-anchored forms of gD. Both membrane-bound and soluble gD were modified with M6P residues and were localized to endosomes that contained the 275-kDa MPR or the transferrin receptor. Similar results were observed in HSV-infected cells. Cell fractionation experiments showed that gD was not present in lysosomes. However, a mutant form of gD and another HSV glycoprotein, gI, that were not modified with M6P were also found in endosomes in HSV-infected cells. Moreover, a substantial fraction of the HSV nucleocapsid protein VP6 was found in endosomes, consistent with accumulation of virions in an endosomal compartment. Therefore, it appears that HSV glycoproteins and virions are directed to endosomes, by M6P-dependent as well as by M6P-independent mechanisms, either as part of the virus egress pathway or by endocytosis from the cell surface.


Asunto(s)
Endosomas/metabolismo , Manosafosfatos/metabolismo , Proteínas del Envoltorio Viral/metabolismo , Adenoviridae/genética , Animales , Transporte Biológico , Línea Celular , Membrana Celular/metabolismo , Chlorocebus aethiops , Clonación Molecular , Vectores Genéticos , Humanos , Lisosomas/metabolismo , Nucleocápside/metabolismo , Receptores Citoplasmáticos y Nucleares/metabolismo , Solubilidad , Fracciones Subcelulares , Células Vero , Proteínas del Envoltorio Viral/genética , Virión
15.
Am J Infect Control ; 24(1): 13-8, 1996 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-8651515

RESUMEN

BACKGROUND: Mumps is a relatively uncommon disease in the United States, and nosocomial transmission of mumps is rare. METHODS: When a recently arrived Mexican immigrant became ill with mumps in a pediatric hospital in the United States, control measures and careful secondary case surveillance were instituted. Outbreak control included isolation of the patient with symptoms, seclusion of patients potentially incubating mumps virus, and immunization of susceptible patients and health care workers. RESULTS: A 3-year-old patient showed symptoms of mumps 18 days after onset of illness in the index patient. Two employees, a physical therapist and a nurse, became ill with mumps 20 and 28 days after the onset of illness in the index patient. No other hospital or community cases of mumps were identified. CONCLUSIONS: Outbreak control measures were incompletely successful in stopping the spread of mumps. Preadmission immunization of all patients and mumps-specific screening and vaccination of hospital employees might be indicated in such a situation, but such measures are neither easy nor inexpensive.


Asunto(s)
Infección Hospitalaria/epidemiología , Brotes de Enfermedades , Transmisión de Enfermedad Infecciosa de Paciente a Profesional , Paperas/epidemiología , Adulto , Niño , Preescolar , Infección Hospitalaria/prevención & control , Brotes de Enfermedades/prevención & control , Femenino , Humanos , Inmunización , Lactante , Control de Infecciones/métodos , Paperas/diagnóstico , Paperas/fisiopatología , Paperas/prevención & control , Paperas/transmisión , Aislamiento de Pacientes , Utah/epidemiología
16.
J Virol ; 69(6): 3517-28, 1995 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-7745699

RESUMEN

Herpes simplex virus (HSV) glycoprotein D (gD) is essential for virus entry into cells, is modified with mannose-6-phosphate (M-6-P), and binds to both the 275-kDa M-6-P receptor (MPR) and the 46-kDa MPR (C. R. Brunetti, R. L. Burke, S. Kornfeld, W. Gregory, K. S. Dingwell, F. Masiarz, and D. C. Johnson, J. Biol. Chem. 269:17067-17074, 1994). Since MPRs are found on the surfaces of mammalian cells, we tested the hypothesis that MPRs could serve as receptors for HSV during virus entry into cells. A soluble form of the 275-kDa MPR, derived from fetal bovine serum, inhibited HSV plaques on monkey Vero cells, as did polyclonal rabbit anti-MPR antibodies. In addition, the number and size of HSV plaques were reduced when cells were treated with bovine serum albumin conjugated with pentamannose-phosphate (PM-PO4-BSA), a bulky ligand which can serve as a high-affinity ligand for MPRs. These data imply that HSV can use MPRs to enter cells; however, other molecules must also serve as receptors for HSV because a reasonable fraction of virus could enter cells treated with even the highest concentrations of these inhibitors. Consistent with the possibility that there are other receptors, HSV produced the same number of plaques on MPR-deficient mouse fibroblasts as were produced on normal mouse fibroblasts, but there was no inhibition with PM-PO4-BSA with either of these embryonic mouse cells. Together, these results demonstrate that HSV does not rely solely on MPRs to enter cells, although MPRs apparently play some role in virus entry into some cell types and, perhaps, act as one of a number of cell surface molecules that can facilitate entry. We also found that HSV produced small plaques on human fibroblasts derived from patients with pseudo-Hurler's polydystrophy, cells in which glycoproteins are not modified with M-6-P residues and yet production of infectious HSV particles was not altered in the pseudo-Hurler cells. In addition, HSV plaque size was reduced by PM-PO4-BSA; therefore, it appears that M-6-P residues and MPRs are required for efficient transmission of HSV between cells, a process which differs in some respects from entry of exogenous virus particles.


Asunto(s)
Fusión de Membrana , Receptor IGF Tipo 2/fisiología , Simplexvirus/fisiología , Animales , Línea Celular , Chlorocebus aethiops , Fibroblastos/virología , Humanos , Ratones , Fosforilación , Células Vero , Ensayo de Placa Viral
17.
J Biol Chem ; 269(25): 17067-74, 1994 Jun 24.
Artículo en Inglés | MEDLINE | ID: mdl-8006011

RESUMEN

Herpes simplex viruses (HSV) use multiple and sequential receptors to enter host cells. HSV glycoprotein D (gD) has been implicated in binding to cellular receptors that facilitate virus penetration into cells. We used soluble forms of gD that were expressed in Chinese hamster ovary cells to characterize and identify a putative cellular receptor for HSV as the 275-kDa mannose 6-phosphate/insulin-like growth factor II receptor. Soluble gD also bound to the 46-kDa cation-dependent mannose 6-phosphate (Man-6-P) receptor and was extensively modified with Man-6-P residues on its Asn-linked oligosaccharides. Additionally, soluble gD was a high affinity substrate for N-acetylglucosamine-1-phosphotransferase, the first enzyme in the biosynthetic pathway for the addition of Man-6-P residues to lysosomal enzymes. The membrane form of gD immunoprecipitated from HSV-infected cells also bound to the 275-kDa mannose 6-phosphate/insulin-like growth factor II receptor, albeit poorly, and only a small fraction of the membrane gD was modified with Man-6-P. Notwithstanding this low level of mannose phosphorylation, the interaction between gD and Man-6-P receptors may play a role in some aspect of virus entry or egress.


Asunto(s)
Herpesvirus Humano 1/metabolismo , Manosafosfatos/metabolismo , Receptor IGF Tipo 2/metabolismo , Receptores Virales/metabolismo , Proteínas del Envoltorio Viral/metabolismo , Secuencia de Aminoácidos , Animales , Línea Celular , Humanos , Glicoproteínas de Membrana/metabolismo , Datos de Secuencia Molecular , Peso Molecular , Unión Proteica , Solubilidad , Relación Estructura-Actividad
18.
J Virol ; 68(2): 834-45, 1994 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-8289387

RESUMEN

Herpes simplex virus (HSV) glycoproteins E and I (gE and gI) can act as a receptor for the Fc domain of immunoglobulin G (IgG). To examine the role of HSV IgG Fc receptor in viral pathogenesis, rabbits and mice were infected by the corneal route with HSV gE- or gI- mutants. Wild-type HSV-1 produced large dendritic lesions in the corneal epithelium and subsequent stromal disease leading to viral encephalitis, whereas gE- and gI- mutant viruses produced microscopic punctate or small dendritic lesions in the epithelium and no corneal disease or encephalitis. These differences were not related to the ability of the gE-gI oligomer to bind IgG because the differences were observed before the appearance of anti-HSV IgG and in mice, in which IgG binds to the Fc receptor poorly or not at all. Mutant viruses produced small plaques on monolayers of normal human fibroblasts and epithelial cells. Replication of gE- and gI- mutant viruses in human fibroblasts were normal, and the rates of entry of mutant and wild-type viruses into fibroblasts were similar; however, spread of gE- and gI- mutant viruses from cell to cell was significantly slower than that of wild-type HSV-1. In experiments in which fibroblast monolayers were infected with low multiplicities of virus and multiple rounds of infection occurred, the presence of neutralizing antibodies in the culture medium caused the yields of mutant viruses to drop dramatically, whereas there was a lesser effect on the production of wild-type HSV. It appears that cell-to-cell transmission of wild-type HSV-1 occurs by at least two mechanisms: (i) release of virus from cells and entry of extracellular virus into a neighboring cell and (ii) transfer of virus across cell junctions in a manner resistant to neutralizing antibodies. Our results suggest that gE- and gI- mutants are defective in the latter mechanism of spread, suggesting the possibility that the gE-gI complex facilitates virus transfer across cell junctions, a mode of spread which may predominate in some tissues. It is ironic that the gE-gI complex, usually considered an IgG Fc receptor, may, through its ability to mediate cell-to-cell spread, actually protect HSV from IgG in a manner different than previously thought.


Asunto(s)
Comunicación Celular , Herpesvirus Humano 1/patogenicidad , Proteínas del Envoltorio Viral/genética , Animales , Transporte Biológico , Células Cultivadas , Femenino , Fibroblastos/microbiología , Herpesvirus Humano 1/genética , Humanos , Uniones Intercelulares , Ratones , Mutagénesis , Receptores Fc , Ensayo de Placa Viral , Virulencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...